series-a
Stage
1
Investors
About
Mesentech develops prostaglandin prodrugs intended to promote musculoskeletal tissue regeneration.
Explore Mesentech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.